home / stock / pavmz / pavmz news


PAVMZ News and Press, PAVmed Inc. Series Z Warrant From 10/18/21

Stock Information

Company Name: PAVmed Inc. Series Z Warrant
Stock Symbol: PAVMZ
Market: NASDAQ
Website: pavmed.com

Menu

PAVMZ PAVMZ Quote PAVMZ Short PAVMZ News PAVMZ Articles PAVMZ Message Board
Get PAVMZ Alerts

News, Short Squeeze, Breakout and More Instantly...

PAVMZ - Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering

NEW YORK, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), today announced the closing on October 1...

PAVMZ - Lucid Diagnostics Announces Pricing of Initial Public Offering

Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), today announced the pricing of its initial public offering of 5,000,000 shares o...

PAVMZ - PAVmed Acquires EsophaCap Manufacturer CapNostics LLC

PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today announced a wholly owned subsidiary of the Company has entered into a definitive membership interests...

PAVMZ - PAVmed to Host Digital Health Virtual Investor Event

Veris Health: Bringing Digital Health to Cancer Care October 26, 2021, from 1 p.m. to 3 p.m. EDT PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology com...

PAVMZ - PAVmed Subsidiary Veris Health Joins Microsoft for Startups Global Program and Engages Loka as Software Development Partner

Veris remote digital healthcare platform to utilize first intelligent implantable vascular access port with biologic sensors and wireless communication to improve cancer care PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a hi...

PAVMZ - PAVmed to Participate in September Investor and MedTech Conferences

Presentations scheduled at Lake Street Capital Markets BIG5, Cantor Fitzgerald Virtual Global Healthcare, and The MedTech Conference PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multi-product...

PAVMZ - PAVmed Provides Business Update and Preliminary Second Quarter 2021 Financial Results

Conference call to be held today at 4:30 PM EDT PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today provided a business update for the Compa...

PAVMZ - PAVmed Subsidiary Lucid Diagnostics Launches First Lucid Test Centers

Patients undergoing esophageal precancer testing at centers in Phoenix metro area PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today announ...

PAVMZ - PAVmed to Present at the 41st Annual Canaccord Genuity Growth Conference

PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief Executive Officer will present...

PAVMZ - Global Industry Executive Aster Angagaw Joins PAVmed Subsidiary Lucid Diagnostics' Board of Directors

PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that prominent global industry executive Aster Angagaw has joined the Board of Directors o...

Previous 10 Next 10